Pagkakaiba sa mga pagbabagong ng "Pagbabakuna kontra COVID-19 sa Pilipinas"

walang buod ng pagbabago
(umpisa)
Tatak: Binago sa mobile Pagbabago sa web gamit mobile
 
Tatak: Binago sa mobile Pagbabago sa web gamit mobile
| website =
}}
TheAng '''pagbabakuna kontra COVID-19 vaccination program in thesa PhilippinesPilipinas''' isay anisang ongoingprograma massupang [[immunization]]mabakunahan campaignang againstmga mamamayan kontra ''[[severe acute respiratory syndrome coronavirus 2]]'' (SARS-CoV-2), theang virus thatna causesnagdudulot ng ''[[COVID-19|coronavirus disease 2019]]'' (COVID-19), inbilang responsetugon to thesa [[Pandemya ng COVID-19 pandemicsa in the PhilippinesPilipinas|ongoing pandemickasalukuyang inpandemya thesa countrybansa]].
 
The [[Food and Drug Administration (Philippines)|Food and Drug Administration]] (FDA) has issued [[emergency use authorization]]s (EUA) to 8 [[COVID-19 vaccine]]s (in chronological order): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], [[CoronaVac|Sinovac]], [[Sputnik V COVID-19 vaccine|Sputnik V]], [[Johnson & Johnson COVID-19 vaccine|Janssen]], [[Covaxin]], [[Moderna COVID-19 vaccine|Moderna]], and [[BBIBP-CorV|Sinopharm]]. There are eight other vaccines on order for the program, at varying stages of development.
1,440

edit